Keywords: Executive appointments, Merck & Co, Actelion, Jazz Pharma

Executive appointments at Merck & Co, Actelion and Jazz Pharma

Article | 28 September 2011

Print This

US drug giant Merck & Co (NYSE: MRK) has appointed Cuong Viet Do as chief strategy officer, effective October 3. In ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in